What is Alnylam Pharmaceuticals's common stock?

Alnylam Pharmaceuticals (ALNY) reported common stock of 250M in Q2 2026.

How has Alnylam Pharmaceuticals's common stock changed year-over-year?

Alnylam Pharmaceuticals's common stock decreased by 0.0% year-over-year, from 250M to 250M.

What is the long-term trend for Alnylam Pharmaceuticals's common stock?

Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's common stock has grown at a 2.6% compound annual growth rate (CAGR), from 1.2M to 1.3M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Alnylam Pharmaceuticals ALNY Common Stock

Common Stock at other companies

Ionis PharmaceuticalsIONS

300M0.0%

Arrowhead ResearchARWR

$236K+2.6%

PTC TherapeuticsPTCT

$81K+3.8%

Assembly BiosciencesASMB

$16K+100%

Arbutus Biopharma CorporationABUS

$1.44B+2.0%

Wave Life SciencesWVE

$1.63B+36.6%

Other financials

Income statement

See full

Revenue$1.3B+66.9%

Gross profit$992.7M+57.2%

Operating income$231.4M+1,529%

Net income$164.5M+348%

EPS (diluted)$1.21+337%

Balance sheet

See full

Cash & equivalents$1.7B+53.2%

Total debt$256.4M-5.2%

Total equity$1.4B+440%

Total assets$5.6B+21.7%

Cash flow

See full

Operating cash flow$326.7M+113%

CapEx$34.7M+143%

Free cash flow$292.0M+109%

Valuation

See full

Market cap$38.27B-13.6%

Enterprise value$36.81B-15.3%

P/E52.2×—

P/S8×-10.0×

Profitability

See full

Gross margin79.8%-4.1pp

Operating margin20.8%+16.5pp

Net margin15.3%+10.7pp

FCF margin16.5%+14.8pp

Returns & leverage

See full

Return on equity91.4%—

Debt / equity0.2×-0.9×

Current ratio3.1×+0.3×

Where this comes from

Reported directly by Alnylam Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alnylam Pharmaceuticals's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alnylam Pharmaceuticals's common stock?: Alnylam Pharmaceuticals (ALNY) reported common stock of 250M in Q2 2026.
How has Alnylam Pharmaceuticals's common stock changed year-over-year?: Alnylam Pharmaceuticals's common stock decreased by 0.0% year-over-year, from 250M to 250M.
What is the long-term trend for Alnylam Pharmaceuticals's common stock?: Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's common stock has grown at a 2.6% compound annual growth rate (CAGR), from 1.2M to 1.3M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).